Скачать (PDF, 1.67MB)

Update on the Global Fund’s Procurement Strategy. WHO UNAIDS Annual Meeting with Pharmaceutical Stakeholders

Key outcomes

• The long term collaborative agreements will support continuous supply through improved lead times and better delivery performance
• Supply risks mitigated with multiple awardees per product and diversification of API sources
• Proposals received for improvements to the supply of paediatric products
• Cost reductions for optimal 1st & 2nd line regimens for adults & children: immediate and further reductions over time
• The new approach will drive further improvements through the deployment of objectivized annual business plans
• Vendor managed inventory linked to commitments a viable solution to respond to stock-outs across Global Fund portfolio
• Delivers Global Fund’s Market Shaping Strategy through underpinning long term sustainability both at a product and market level.